Intraocular lens power calculation using total keratometry and ray tracing in eyes with previous small incision lenticule extraction - A case series.
Autor: | Lischke R; University Eye Hospital, Ludwig-Maximilians-University, Munich, Germany.; Department of Ophthalmology and Optometry, Medical University of Innsbruck, Austria., Wiltfang R; SMILE Eyes Clinic, Munich, Germany.; SMILE Eyes Clinic, Trier, Germany., Bechmann M; SMILE Eyes Clinic, Munich, Germany.; SMILE Eyes Clinic, Trier, Germany., Kreutzer TC; University Eye Hospital, Ludwig-Maximilians-University, Munich, Germany., Priglinger SG; University Eye Hospital, Ludwig-Maximilians-University, Munich, Germany.; SMILE Eyes Clinic, Austria., Dirisamer M; University Eye Hospital, Ludwig-Maximilians-University, Munich, Germany.; SMILE Eyes Clinic, Austria., Luft N; University Eye Hospital, Ludwig-Maximilians-University, Munich, Germany.; SMILE Eyes Clinic, Austria. |
---|---|
Jazyk: | angličtina |
Zdroj: | American journal of ophthalmology case reports [Am J Ophthalmol Case Rep] 2024 Feb 29; Vol. 34, pp. 102037. Date of Electronic Publication: 2024 Feb 29 (Print Publication: 2024). |
DOI: | 10.1016/j.ajoc.2024.102037 |
Abstrakt: | Purpose: To assess the IOL power calculation accuracy in post-SMILE eyes using ray tracing and a range of total keratometry based IOL calculation formulae. Observations: Ray tracing showed excellent predictability in IOL power calculation after SMILE and its accuracy was clinically comparable with the Barrett TK Universal II and Haigis TK formula. Conclusions and Importance: Incorporating posterior corneal curvature measurements into IOL power calculation after SMILE seems prudent. The ray tracing method as well as selected TK-based formulae yielded excellent accuracy and should be favored in post-SMILE eyes. Competing Interests: The authors have no proprietary or financial or any other competing interest in any of the materials or equipment mentioned in this study. Rainer Wiltfang: Member scientific board Carl Zeiss Meditec AG. Siegfried G. Priglinger: Novartis Pharma GmbH - advisory board/honoraria; Pharm Allergan - advisory board/honoraria; Zeiss - advisory board/honoraria; BVI - advisory board/honoraria; Bayer - advisory board/honoraria; Alcon - advisory board/honoraria; B&L – honoraria; Oxurion – honoraria; Örtli – honoraria; Vitrequ – honoraria. M. Dirisamer: Carl Zeiss Meditec AG: Lecture honoraria, Travel expenses. N. Luft: Carl Zeiss Meditec AG: Lecture honoraria. Other authors: None. (© 2024 Published by Elsevier Inc.) |
Databáze: | MEDLINE |
Externí odkaz: |